Posts Tagged 'Gilenya'

Gilenya a Possible Link to Rare Brain Infection

The U.S. Food and Drug Administration has issued an alert to the public indicating that a patient in Europe diagnosed with possible multiple sclerosis has developed a rare and serious brain infection after taking Gilenya.

Gilenya is used to treat relapsing forms of MS, a nervous system disease that affects the brain and spinal cord. This is the first case of progressive multifocal leukoencephalopathy (PML), which is a rare and serious brain infection caused by the John Cunningham ...

continue reading...

FDA issues stricter warning for epilepsy drug Gilenya

The U.S. Food and Drug Administration has reviewed Novartis AG’s multiple sclerosis drug Gilenya, and concluded that patients who’ve suffered a heart attack or stroke within the past six months shouldn’t take it.

The review came about after a 59-year-old patient died in November, less than 24 hours after taking the first dose of the drug.

Europe’s drug regulator, the European Medicines Agency, recently requested stronger safety warnings for Gilenya after the agency concluded its review of the drug.

According to Dow Jones ...

continue reading...